- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Hantavirus
- Puumala virus
- Blood sample
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- Adults (18-64 years)
- General population
- Hospital
- Monkeypox virus
- Blood sample
- Vaccination
- MVA-BN
- Adults (18-64 years)
- General population
- Outpatient clinic
- STD/STI clinic
- Monkeypox virus
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- HIV
- Mycoplasma spp.
- Trichomonas vaginalis
- Ureaplasma
- Hepatitis B virus
- Hepatitis C virus
- Herpes simplex virus
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- STD/STI clinic
- Monkeypox virus
- Blood sample
- Anorectal swab
- Saliva sample
- Vaccination
- MVA-BN
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- STD/STI clinic
- Monkeypox virus
- Blood sample
- Anorectal swab
- Saliva sample
- Semen sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Monkeypox virus
- Vaccination
- MVA-BN
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Non pharmacological intervention
- Rehabilitation
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- General population
- Infants (<1 year)
- Children (1-11 years)
- Adolescents (12-17 years)
- Community
- Household
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Respiratory syncytial virus
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab